| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |